Sponsored Links

FDA: Treatment With Angiotensin Receptor Blockers For High Blood Pressure Does Not Increase Risk Of Cancer PDF Print E-mail
Medical News - Hypertension
The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications...

Read more: Hypertension News From Medical News Today